Nisa Investment Advisors
LRMR icon

Nisa Investment Advisors’s Larimar Therapeutics LRMR Stock Holding History

Nisa Investment Advisors’s Portfolio LRMR Stock Details LRMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$31.1K Buy
6,903
+5,265
+321% +$21K ﹤0.01% 1862
2025
Q4 		$6.24K Hold
1,638
– – ﹤0.01% 2397
2025
Q3 		$5.29K Hold
1,638
– – ﹤0.01% 2428
2025
Q2 		$4.73K Sell
1,638
-2,118
-56% -$4.9K ﹤0.01% 2457
2025
Q1 		$8.07K Buy
+3,756
New +$11.9K ﹤0.01% 2150
2024
Q4 		– Sell
-118
Closed -$773 – 3029
2024
Q3 		$773 Buy
118
+69
+141% +$555 ﹤0.01% 2632
2024
Q2 		$355 Buy
49
+46
+1,533% +$352 ﹤0.01% 2746
2024
Q1 		$23 Buy
+3
New +$23 ﹤0.01% 2776

Other funds holding LRMR

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Nisa Investment Advisors's LRMR Position: Q1 2026 in Review

Nisa Investment Advisors increased its Larimar Therapeutics (LRMR) stake by 321% in Q1 2026, buying an estimated $21K and bringing the position to 6,903 shares worth $31.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1862.

Nisa Investment Advisors first reported a position in LRMR in Q1 2024 and has held it in 8 quarters since. 162 funds tracked by Wall St. Rank hold LRMR as of Q1 2026.

  • Nisa Investment Advisors held 6,903 shares of Larimar Therapeutics worth $31.1K as of Q1 2026.
  • Nisa Investment Advisors bought 5,265 Larimar Therapeutics shares in Q1 2026, an estimated $21K.
  • Larimar Therapeutics made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q1 2026, its #1862 holding.
  • Nisa Investment Advisors first reported a position in Larimar Therapeutics in Q1 2024 and has held it in 8 quarters since.
  • 162 funds tracked by Wall St. Rank held Larimar Therapeutics as of Q1 2026.

Based on Nisa Investment Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.